Freeze Drying for Nutraceutical Ingredients

Botanical extracts, probiotics, enzymes and other sensitive ingredients require different formulation and drying strategies. Activity is confirmed against an agreed test method rather than assumed from the drying temperature — the process must prove what the label claims.

Pain points we solve

Activity lossProbiotics, enzymes and markers degrade with heat; a controlled low-temperature route protects them where the test data confirms it.

Batch-to-batch driftFormulation and fill depth changes shift the cycle; trials document the limits that keep results repeatable.

Stability claimsResidual moisture and packaging must support the shelf life the product claims.

Scale-up gapA bench result is not a production guarantee; the pilot data is converted into a sized configuration.

Define the quality target

Share the target activity or marker, starting solids, fill depth, residual moisture, reconstitution behavior and shelf-life requirements. Trials can compare process routes and identify what must be controlled during scale-up.

Evaluate the full chain

Pre-treatment, freezing, dryer cycle, moisture-protective handling and packaging all affect the finished ingredient. A pilot unit defines the route, then a biomedical dryer or spray freeze dryer carries it to production.

Related guidance

Pilot to production — what changes at scale.
Collapse and glass transition — the stability limit for sensitive formulations.

Retention evidence. Activity and retention results are supported by material-specific test data.

Request a material feasibility review →